• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Exome Sequencing Improves Ability to Diagnose Neurogenetic Disorders

  Exome Sequencing Improves Ability to Diagnose Neurogenetic  
 

Illustration: Maja Moden

UCLA researchers have found that a state-of-the-art molecular genetic test greatly improves the speed and accuracy for diagnosing neurogenetic disorders. The discovery could lead to better care for people with rare diseases like spinocerebellar ataxia, leukodsystrophy and spastic paraplegia. The test, called exome sequencing, involves determining the order of the genes in a person’s genome. When used in concert with a patient evaluation and family medical history, the approach can help doctors identify disorders that may have gone undiagnosed for years, says Brent Fogel, MD (RES ’07, FEL ’09), PhD, director of the UCLA Neurogenetics Clinic and associate professor of neurology and human genetics.

Exome sequencing is more efficient and less costly than the type of genetic testing that has been more commonly used, Dr. Fogel says, and a proper diagnosis can end what for many patients is an agonizing journey just to find a name for their conditions. The growing body of evidence supporting the use of the test, and the demonstrated benefits to patients, should lead to greater insurance coverage of the test, he says. “Despite extensive literature supporting the use of this technology, many insurance companies still consider it to be investigational and may refuse coverage. Our article outlines the appropriate use, benefits and limitations of exome sequencing that these companies need to consider when making coverage decisions.”

UCLA has been a leader in using the test as a diagnostic tool since 2012. Dr. Fogel and his team were among the first to adopt the technology for routine neurological practice, and he has been a strong advocate for wider use. Dr. Fogel and his colleagues wrote a study in 2014 about exome sequencing that was published in the Journal of the American Medical Association Neurology. That research found that 20 percent of a group of people with spinocerebellar ataxia could be diagnosed immediately using the technique. Additionally, they discovered that useful genetic information could be identified in more than 60 percent of the subjects, regardless of their age when the disease began or their family history.

Clinical Exome Sequencing in Neurologic Disease,” Neurology Clinical Practice, April 2016

 


Previous
Genetic Evolution of Zika Virus Unraveled
Next
Impaired Stress Hormone before Pregnancy Predicts Lower-birthweight Babies


YOU ARE VIEWING

Summer 2016

Summer 2016
E-Brochure
Printable PDF
IN THIS ISSUE
  • For the Public Good
  • Genetic Evolution of Zika Virus Unraveled
  • Exome Sequencing Improves Ability to Diagnose Neurogenetic Disorders
  • Impaired Stress Hormone before Pregnancy Predicts Lower-birthweight Babies
  • Surgery Better than Widely Used Medications to Treat Osteoporosis
  • Steps toward Potential Treatments for Central Nervous System Injury
  • Majority of California Adults Have Prediabetes or Diabetes
  • Promising New Approach to Treat Duchenne Muscular Dystrophy
  • A Key to Unlock Effective Personalized Medicine
  • PET Imaging Technology to Improve Cancer Treatment
  • Empathy for the Empathically Challenged
  • Glial Scarring Enhances Nerve-cell Regrowth
  • Helping U Help the Community: The Winners Are ...
  • Raising the Bar
  • Memories Are Made of This
  • Balms of Gilead
  • Dramatic Turn
  • Healthy Lifestyle, Healthy Memory
  • Awards & Honors
  • Reflection: Building a Legacy
  • In Her Own Words: Marie Crandall, MD ’96, MPH
  • Standing on the Shoulders of a Giant
  • UCLA Joins Parker Institute Collaboration to Advance Cancer Immunotherapy Research
  • UCLA Honors Longtime Benefactors with The UCLA Medal, Celebrates Inaugural Chair Holders
  • Gift from Arline and Henry Gluck to Pioneer Innovative Stroke Treatment
  • Taking on the Grand Challenge of Depression
  • Samuel Steinberg: Celebrating a Life of Compassion
  • Taste for a Cure: A Winning Event
  • UCLA Neurosurgery Celebrates Tom and Nadia Davies' Philanthropy and the Inaugural Davies Chair Holder
  • UCLA Helps Young People Develop Sound Bodies and Minds
  • New UCLA Operation Mend Program Treats the Hidden Wounds of War
  • An Afternoon of Good Food and Friends at Vibiana Raises Money for Scholarships
  • Fourth Annual Tour de Pier Fundraiser Tops $1 Million for Cancer Research and Services
  • Generous Philanthropy Launches UCLA Center to Support Emotionally Healthy Children
  • Gifts
  • Faculty Giving Back
  • In Memoriam
  • Family Support
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth